Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (7)

2024

  1. Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 547-554

2021

  1. Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma

    European Journal of Cancer, Vol. 158, pp. 156-168

2018

  1. Association of APOA5 and APOC3 Genetic Polymorphisms with Severity of Hypertriglyceridemia in Patients with Cutaneous T-Cell Lymphoma Treated with Bexarotene

    JAMA Dermatology, Vol. 154, Núm. 12, pp. 1424-1431

  2. Lymph Node Dissection in Patients With Melanoma and Sentinel Lymph Node Metastasis: An Updated, Evidence-Based Decision Algorithm

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 5, pp. 390-398

  3. Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients

    Journal of the American Academy of Dermatology, Vol. 79, Núm. 5, pp. 892-898

2017

  1. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine

    Nature, Vol. 546, Núm. 7660, pp. 676-680

2011

  1. Primary cutaneous CD30 anaplastic large-cell lymphomas show a heterogeneous genomic profile: An oligonucleotide arrayCGH approach

    Journal of Investigative Dermatology